Law Firm Investigates Deals for Option Care Health, Pacira Biosciences, and Others
Law firm Halper Sadeh LLC has initiated investigations into corporate transactions involving Option Care Health, Pacira Biosciences, RXO, and Boundless Bio. The focus is on potential securities law violations and breaches of fiduciary duty to shareholders.
New York, NY – October 12, 2026 – Investor rights law firm Halper Sadeh LLC is investigating four companies for potential violations of federal securities laws and/or breaches of fiduciary duty to shareholders.
The companies under scrutiny include Option Care Health, Inc. (NASDAQ: OPCH), which is being sold to CD&R and McKesson Corporation for $32.05 per share. Pacira BioSciences, Inc. (NASDAQ: PCRX) is being sold to Viatris Inc. for $36.50 per share in cash. RXO Inc. (NYSE: RXO) is being acquired by C.H. Robinson Worldwide, Inc. in a deal valued at $17.25 per share in cash and stock, with RXO shareholders expected to own 11% of the combined entity. Boundless Bio, Inc. (NASDAQ: BOLD) is merging with Serapha Bio, Inc., a transaction where Boundless Bio shareholders are anticipated to hold approximately 3.7% of the merged company.
Halper Sadeh LLC stated that its investigations aim to determine if the management of these companies have secured fair terms for their shareholders and if the deal terms may impede superior competing offers. The firm is encouraging shareholders to contact them to discuss their rights and options at no cost.
The law firm represents investors globally who have been victims of securities fraud and corporate misconduct. Halper Sadeh LLC has a history of implementing corporate reforms and recovering millions of dollars for defrauded investors.
These investigations are ongoing. The firm notes that past results do not guarantee a similar outcome.